Literature DB >> 2786680

The screening of propofol in MHS swine.

M Raff1, G G Harrison.   

Abstract

This study investigated the use of propofol in swine genetically susceptible to malignant hyperthermia (MH). Thirteen animals were exposed to 2% halothane in inspired air, a propofol infusion of 12 mg.kg-1.hr-1 for up to 45 min, or a combination of both. When MH was triggered the animals were treated with dantrolene. Mean onset time of malignant hyperthermia on exposure to halothane alone was 7.2 min +/- 3.0 min and onset with propofol and halothane was 5.0 +/- 2.5 min. In no instance did propofol alone trigger the syndrome nor was there a statistical difference (P less than 0.05) in onset time when the drug was used in conjunction with halothane. On the basis of these results, we conclude that propofol is almost certainly safe for use in humans who are susceptible to MH.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786680

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  Propofol in a patient at risk for malignant hyperthermia: report of a case.

Authors:  Yuka Shimonagano; Yoshitami Kadota; Koichi Kawasaki; Takashi Gushiken; Nozomu Yoshimura
Journal:  J Anesth       Date:  1998-06       Impact factor: 2.078

2.  A new intravenous anesthetic agent: propofol.

Authors:  T Duke
Journal:  Can Vet J       Date:  1995-03       Impact factor: 1.008

3.  Propofol for anesthesia in a patient susceptible to malignant hyperthermia.

Authors:  M B Rosenberg
Journal:  Anesth Prog       Date:  1991 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.